drugset / Trial / NCT00310466

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

NCT00310466 ↗

Phase 3 Completed 226 enrolled ALK-Abelló A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The trial is performed to assess the efficacy and safety of SLIT One birch for treatment of birch pollen induced allergy

Timeline

Start
2005-06
Primary completion
2006-08
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator SLITone(TM) Birch Unknown 200 unknown Other

Indications